HymanBMussMD

Oncology • Chapel Hill, NC

Professor of Medical Oncology, University of North Carolina School of Medicine

Join to view full profile

Dr. Muss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Muss' full profile

Already have an account?

Office
143 W Franklin St
Chapel Hill, NC 27516
Phone+1 919-966-4131

Fax+1 984-974-2603

Education & Training

Brigham and Women's HospitalResidency, Internal Medicine, 1972 - 1974
Brigham and Women's HospitalResidency, Internal Medicine, 1972 - 1973
Brigham and Women's HospitalResidency, Internal Medicine, 1968 - 1970
State University of New York Downstate Medical Center College of MedicineClass of 1968

Certifications & Licensure

NC State Medical License 2009 - 2025
VT State Medical License 1996 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FASCO) American Society of Clinical Oncologists, 2008
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Letrozole After Tamoxifen in Treating Women With Breast Cancer Start of enrollment: 1998 Aug 24
Completed
Phase 3
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer Start of enrollment: 2001 Sep 01
Completed
Phase 3
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer Start of enrollment: 2003 Aug 01
Completed
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. Start of enrollment: 2006 Dec 01
Suspended
Phase 1, Phase 2
Registry of Older Patients With Cancer Start of enrollment: 2009 Sep 01
Recruiting
Biomarkers in Blood Samples From Older Breast Cancer Survivors Start of enrollment: 2010 Jan 01
Completed
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2011 Apr 20
Active, not recruiting
Phase 2
Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients Start of enrollment: 2010 Dec 01
Active, not recruiting
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study Start of enrollment: 2011 Sep 09
Active, not recruiting
Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer Start of enrollment: 2012 Jul 01
Completed
Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer Start of enrollment: 2012 Jul 23
Completed
Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy Start of enrollment: 2012 Oct 01
Completed
Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
Terminated
The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer Start of enrollment: 2014 Mar 01
Completed
Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer Start of enrollment: 2014 Jun 01
Completed
Not Applicable
The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older Start of enrollment: 2014 Jun 01
Completed
Not Applicable
Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging Start of enrollment: 2018 Feb 28
Recruiting
Not Applicable
Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer Start of enrollment: 2020 Jan 21
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.
Danielle M File, Yara Abdou, Jeremy Force, Dominic T Moore, Carey K Anders
Clinical Breast Cancer. 2024-12-01
Associations of social vulnerability index with patient-reported outcomes in women treated with chemotherapy for early-stage breast cancer.
Natalie Almond, Allison M Deal, Annie Page, Kirsten A Nyrop, Hyman B Muss
The Oncologist. 2024-11-26
The Role of p16Ink4a as an Early Predictor of Physiological Decline during Natural Aging.
Lingzi Tang, Siarhei Hladyshau, Allison Ross, Kirsten A Nyrop, Amy Entwistle
Medrxiv. 2024-11-22

Journal Articles

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society

Press Mentions

Xeloda Still Inferior for Older Patients with Early Breast CancerJuly 31st, 2019
Cancer Patients, Doctors Find Healing, Health in ExerciseMay 3rd, 2019
Older Breast Cancer Patients Require Special ConsiderationSeptember 24th, 2017
Join now to see all

Grant Support

Cancer Center Calgb ParticipationNational Cancer Institute1998–2002
Core--Clinical Research ManagementNational Cancer Institute1997–2002
Modulation Of 5-FU Pharmacology By PALA And DipyridamoleNational Cancer Institute1994
Cccwfu Breast Cancer Research Program Planning GrantNational Cancer Institute1994
Modulation Of 5-FU Pharmacology By PALA &DipyridamoleNational Cancer Institute1993